TargetMol

Succinylcholine Chloride Dihydrate

Product Code:
 
TAR-T6684
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6684-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6684-25mg25mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6684-50mg50mg£123.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6684-100mg100mg£165.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6684-200mg200mg£242.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Succinylcholine Chloride Dihydrate is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker.
CAS:
6101-15-1
Formula:
C14H34Cl2N2O6
Molecular Weight:
397.33
Pathway:
Neuroscience
Purity:
0.9991
SMILES:
O.O.[Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
Target:
AChR

References

Schmutz, C., & Muhlebach, S. (1991). Stability of succinylcholine chloride injection.?American Journal Of Health-System Pharmacy,?48(3), 501-506. doi: 10.1093/ajhp/48.3.501 Ward, F., Swaim, S., Ohanesian, N., & Mclaughlin, H. (1969). The effects of hyaluronidase on the immobilization of goats by intramuscular succinylcholine chloride.?Can J Comp Med,?33(1), 20-4.